{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:39:43Z","timestamp":1791848383498,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00105-024-05303-0","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T11:02:39Z","timestamp":1708081359000},"page":"225-231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Skleromyx\u00f6dem","Scleromyxedema"],"prefix":"10.1007","volume":"75","author":[{"given":"Cord","family":"Sunderk\u00f6tter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"key":"5303_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jaad.2013.01.007","volume":"69","author":"F Rongioletti","year":"2013","unstructured":"Rongioletti\u00a0F, Merlo\u00a0G, Cinotti\u00a0E et\u00a0al (2013) Scleromyxedema: a\u00a0multicenter study of characteristics, comorbidities, course, and therapy in 30\u00a0patients. J\u00a0Am Acad Dermatol 69:66\u201372","journal-title":"J Am Acad Dermatol"},{"key":"5303_CR2","unstructured":"Knobler R, Geroldinger-Simi\u0107 M, Kreuter A et\u00a0al (2024im) European dermatology forum-updated guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema and scleredema. J\u00a0Eur Acad Dermatol Venereol"},{"key":"5303_CR3","first-page":"742","volume-title":"Dermatology","author":"F Rongioletti","year":"2017","unstructured":"Rongioletti\u00a0F (2017) Mucinoses. In: Bolognia\u00a0J, Jorizzo\u00a0JL, Schaffer\u00a0JV, Ceroni\u00a0L (Hrsg) Dermatology, 4.\u00a0Aufl. Bd. 1. Elsevier, Philadelphia, S\u00a0742\u2013753","edition":"4"},{"issue":"12","key":"5303_CR4","first-page":"1449","volume":"18","author":"JHO Hoffmann","year":"2020","unstructured":"Hoffmann\u00a0JHO, Enk\u00a0AH (2020) Scleromyx\u00f6dem. J\u00a0Dtsch Dermatol Ges 18(12):1449\u20131467","journal-title":"J Dtsch Dermatol Ges"},{"key":"5303_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.sder.2006.04.001","volume":"25","author":"F Rongioletti","year":"2006","unstructured":"Rongioletti\u00a0F (2006) Lichen myxedematosus (papular mucinosis): new concepts and perspectives for an old disease. Semin Cutan Med Surg 25:100\u2013104","journal-title":"Semin Cutan Med Surg"},{"issue":"1","key":"5303_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/bjd.18004","volume":"182","author":"F Rongioletti","year":"2020","unstructured":"Rongioletti\u00a0F (2020) Primary paediatric cutaneous mucinoses. Br J Dermatol 182(1):29\u201338. https:\/\/doi.org\/10.1111\/bjd.18004 (Epub 2019 Jul 15. PMID: 30977896)","journal-title":"Br J Dermatol"},{"issue":"7","key":"5303_CR7","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/jdv.17983","volume":"36","author":"F Rongioletti","year":"2022","unstructured":"Rongioletti\u00a0F (2022) New and emerging conditions of acquired cutaneous mucinoses in adults. J\u00a0Eur Acad Dermatol Venereol 36(7):1016\u20131024. https:\/\/doi.org\/10.1111\/jdv.17983 (Epub 2022 Feb 17. PMID: 35124832)","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"5303_CR8","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.jaad.2015.12.021","volume":"74","author":"F Rongioletti","year":"2016","unstructured":"Rongioletti\u00a0F, Merlo\u00a0G, Carli\u00a0C, Cribier\u00a0B, Metze\u00a0D, Calonje\u00a0E, Kempf\u00a0W, Stefanato\u00a0CM, Marinho\u00a0E, Kanitakis\u00a0J (2016) Histopathologic characteristics of scleromyxedema: a\u00a0study of a\u00a0series of 34\u00a0cases. J\u00a0Am Acad Dermatol 74(6):1194\u20131200","journal-title":"J Am Acad Dermatol"},{"key":"5303_CR9","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/j.1600-0560.2009.01386.x","volume":"37","author":"F Rongioletti","year":"2010","unstructured":"Rongioletti\u00a0F, Cozzani\u00a0E, Parodi\u00a0A (2010) Scleromyxedema with an interstitial granulomatous-like pattern: a\u00a0rare histologic variant mimicking granuloma annulare. J\u00a0Cutan Pathol 37:1084\u20131087","journal-title":"J Cutan Pathol"},{"issue":"10","key":"5303_CR10","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1093\/rheumatology\/ker209","volume":"50","author":"R Bos","year":"2011","unstructured":"Bos\u00a0R, De waal\u00a0EG, Kuiper\u00a0H, Hazenberg\u00a0BP, Vellenga\u00a0E (2011) Thalidomide and dexamethasone followed by autologous stem cell transplantation for scleromyxoedema. Rheumatology 50(10):1925\u20131926","journal-title":"Rheumatology"},{"key":"5303_CR11","first-page":"1101","volume":"135","author":"T Mah\u00e9vas","year":"2020","unstructured":"Mah\u00e9vas\u00a0T, Arnulf\u00a0B, Bouaziz\u00a0JD et\u00a0al (2020) Plasma cell-directed therapies in monoclonal gammopathy-associated scleromyxedema. Blood 135:1101\u20131110","journal-title":"Blood"},{"key":"5303_CR12","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/acr.23908","volume":"72","author":"CA Mecoli","year":"2020","unstructured":"Mecoli\u00a0CA, Talbot\u00a0CC Jr., Fava\u00a0A et\u00a0al (2020) Clinical and molecular phenotyping in scleromyxedema pretreatment and posttreatment with intravenous immunoglobulin. Arthritis Care Res 72:761\u2013767","journal-title":"Arthritis Care Res"},{"key":"5303_CR13","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/jdv.16136","volume":"34","author":"F Kalli","year":"2020","unstructured":"Kalli\u00a0F, Cioni\u00a0M, Parodi\u00a0A et\u00a0al (2020) Increased frequency of interleukin\u20114 and reduced frequency of interferon\u2011\u03b3 and IL-17-producing CD4+ and CD8+ cells in scleromyxedema. J\u00a0Eur Acad Dermatol Venereol 34:1092\u20131097","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"5303_CR14","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00105-021-04807-3","volume":"72","author":"A Atan","year":"2021","unstructured":"Atan\u00a0A, Michl\u00a0C, Sunderk\u00f6tter\u00a0C (2021) Progrediente Sklerodaktylie bei einem gambischen Farmer. Hautarzt 72(11):1017\u20131019","journal-title":"Hautarzt"},{"key":"5303_CR15","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1007\/s00105-018-4257-8","volume":"69","author":"M Neufeld","year":"2018","unstructured":"Neufeld\u00a0M, Sunderk\u00f6tter\u00a0C, Moritz\u00a0RKC (2018) Skleromyx\u00f6dem. Hautarzt 69:916\u2013921","journal-title":"Hautarzt"},{"key":"5303_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/MD.0b013e3181630835","volume":"87","author":"M Blum","year":"2008","unstructured":"Blum\u00a0M, Wigley\u00a0FM, Hummers\u00a0LK (2008) Scleromyxedema: a\u00a0case series highlighting long-term outcomes of treatment with intravenous immunoglobulin (IVIG). Medicine 87:10\u201320","journal-title":"Medicine"},{"key":"5303_CR17","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1046\/j.1365-2133.2001.04261.x","volume":"144","author":"F Rongioletti","year":"2001","unstructured":"Rongioletti\u00a0F, Hazini\u00a0A, Rebora\u00a0A (2001) Coma associated with scleromyxedema and interferon alfa therapy. Full recovery after steroids and cyclophosphamide combined with plasmapheresis. Br J Dermatol 144:1283\u20131284","journal-title":"Br J Dermatol"},{"key":"5303_CR18","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jaad.2008.11.013","volume":"60","author":"JB Rey","year":"2009","unstructured":"Rey\u00a0JB, Luria\u00a0RB (2009) Treatment of scleromyxedema and the dermatoneuro syndrome with intravenous immunoglobulin. J\u00a0Am Acad Dermatol 60:1037\u20131041","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"5303_CR19","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s00105-023-05159-w","volume":"74","author":"KP Linse","year":"2023","unstructured":"Linse\u00a0KP, Enk\u00a0A, Hoffmann\u00a0J (2023) Dermato-neurologisches Syndrom \u2013 eine akute und lebensbedrohliche Komplikation des Skleromyx\u00f6dems Arndt-Gottron [Dermato-neuro syndrome-an acute and life-threatening complication of scleromyxedema Arndt-Gottron. Dermatologie 74(8):618\u2013620","journal-title":"Dermatologie"},{"key":"5303_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jdcr.2021.10.027","volume":"18","author":"M Fritz","year":"2021","unstructured":"Fritz\u00a0M, Tinker\u00a0D, Wessel\u00a0AW, Morris\u00a0GM, Goldenberg\u00a0L, Fesler\u00a0M, Rukmangadachar\u00a0L, Hurley\u00a0MY (2021) SARS-CoV-2: a\u00a0potential trigger of dermato-neuro syndrome in a\u00a0patient with scleromyxedema. JAAD Case Rep 18:99\u2013102","journal-title":"JAAD Case Rep"},{"issue":"12","key":"5303_CR21","doi-asserted-by":"publisher","first-page":"e237170","DOI":"10.1136\/bcr-2020-237170","volume":"13","author":"JM Larios","year":"2020","unstructured":"Larios\u00a0JM, Ciuro\u00a0J, Sam Varghese\u00a0T, Lyons\u00a0SE (2020) Successful treatment of dermato-neuro syndrome with plasmapheresis. BMJ Case Rep 13(12):e237170","journal-title":"BMJ Case Rep"},{"key":"5303_CR22","doi-asserted-by":"crossref","unstructured":"Li Y, Wang H, Wang A, Zhao G (2023) Dermato-neuro syndrome after COVID-19 infection in a\u00a0patient with scleromyxoedema: previously successful treatment with intravenous immunoglobulins. J\u00a0Dermatol (Oct 13. Epub ahead of print)","DOI":"10.1111\/1346-8138.16994"},{"key":"5303_CR23","first-page":"545","volume":"11","author":"A Espinosa","year":"1993","unstructured":"Espinosa\u00a0A, De Miguel\u00a0E, Morales\u00a0C, Fonseca\u00a0E (1993) Gijon-Ba~nos J. Scleromyxedema associated with arthritis and myopathy: a\u00a0case report. Clin Exp Rheumatol 11:545\u2013547","journal-title":"Clin Exp Rheumatol"},{"key":"5303_CR24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.clindermatol.2006.07.011","volume":"24","author":"CD Cokonis Georgakis","year":"2006","unstructured":"Cokonis Georgakis\u00a0CD, Falasca\u00a0G, Georgakis\u00a0A, Heymann\u00a0WR (2006) Scleromyxedema. Clin Dermatol 24:493\u2013497","journal-title":"Clin Dermatol"},{"key":"5303_CR25","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1365-4362.1989.tb02436.x","volume":"28","author":"MJ Rothe","year":"1989","unstructured":"Rothe\u00a0MJ, Rivas\u00a0R, Gould\u00a0E, Kerdel\u00a0FA (1989) Scleromyxedema and severe myositis. Int J Dermatol 28:657\u2013660","journal-title":"Int J Dermatol"},{"key":"5303_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/09546630152607916","volume":"12","author":"F Ozdag","year":"2001","unstructured":"Ozdag\u00a0F, Akar\u00a0A, Eroglu\u00a0E, Erbil\u00a0H (2001) Acute rhabdomyolysis during the treatment of scleromyxedema with interferon alfa. J\u00a0Dermatolog Treat 12:167\u2013169","journal-title":"J Dermatolog Treat"},{"key":"5303_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1046\/j.1365-4362.2003.01565.x","volume":"42","author":"JJ Pomann","year":"2003","unstructured":"Pomann\u00a0JJ, Rudner\u00a0EJ (2003) Scleromyxedema revisited. Int J Dermatol 42:31\u201335","journal-title":"Int J Dermatol"},{"key":"5303_CR28","first-page":"852","volume":"20","author":"C De Simone","year":"2010","unstructured":"De Simone\u00a0C, Castriota\u00a0M, Carbone\u00a0A, Marini Bettolo\u00a0P, Pieroni\u00a0M, Rongioletti\u00a0F (2010) Cardiomyopathy in scleromyxedema: report of a\u00a0fatal case. Eur J Dermatol 20:852\u2013853","journal-title":"Eur J Dermatol"},{"key":"5303_CR29","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.annder.2010.08.011","volume":"137","author":"M Le Moigne","year":"2010","unstructured":"Le Moigne\u00a0M, Mazereeuw-Hautier\u00a0J, Bonnetblanc\u00a0JM et\u00a0al (2010) Clinical characteristics, outcome of scleromyxedema: a\u00a0retrospective multicenter study. Ann Dermatol Venereol 137:782\u2013788","journal-title":"Ann Dermatol Venereol"},{"key":"5303_CR30","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1177\/019459989110400312","volume":"104","author":"MF Rapp","year":"1991","unstructured":"Rapp\u00a0MF, Guram\u00a0M, Konrad\u00a0HR, Mody\u00a0N, Trapp\u00a0R (1991) Laryngeal involvement in scleromyxedema: a\u00a0case report. Otolaryngol Head Neck Surg 104:362\u2013365.31","journal-title":"Otolaryngol Head Neck Surg"},{"key":"5303_CR31","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/RHU.0b013e31822be61e","volume":"17","author":"YH Lee","year":"2011","unstructured":"Lee\u00a0YH, Sahu\u00a0J, O\u2019Brien\u00a0MS, D\u2019Agati\u00a0VD, Jimenez\u00a0SA (2011) Scleroderma renal crisis-like acute renal failure associated with mucopolysaccharide accumulation in renal vessels in a\u00a0patient with scleromyxedema. J\u00a0Clin Rheumatol 17:318\u2013322","journal-title":"J Clin Rheumatol"},{"key":"5303_CR32","first-page":"1","volume":"1","author":"A Prakashey","year":"2023","unstructured":"Prakashey\u00a0A, Mehta\u00a0H, Bharti Agharia\u00a0HAR (2023) Scleromyxedema: a\u00a0rare case report with dermoscopic findings. Indian J Dermatol Venereol Leprol 1:1\u20133","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"5303_CR33","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jdcr.2019.03.005","volume":"5","author":"P Mendes Bastos","year":"2019","unstructured":"Mendes Bastos\u00a0P, Borges\u00a0AS, Cardoso\u00a0JC, Oliveira\u00a0A (2019) Dermoscopy and reflectance confocal microscopy for the diagnosis of scleromyxedema. JAAD Case Rep 5:451\u2013453","journal-title":"JAAD Case Rep"},{"key":"5303_CR34","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2340\/00015555-1299","volume":"92","author":"M Bidier","year":"2012","unstructured":"Bidier\u00a0M, Zschoche\u00a0C, Gholam\u00a0P, Enk\u00a0AH, Hadaschik\u00a0EN (2012) Scleromyxedema: clinical follow-up after successful treatment with high-dose immunoglobulins reveals different long-term outcomes. Acta Derm Venereol 92:408\u2013409","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"5303_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1136\/ard.61.1.59","volume":"61","author":"A Righi","year":"2002","unstructured":"Righi\u00a0A, Schiavon\u00a0F, Jablonska\u00a0S et\u00a0al (2002) Intravenous immunoglobulins control scleromyxoedema. Ann Rheum Dis 61(1):59\u201361","journal-title":"Ann Rheum Dis"},{"key":"5303_CR36","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1126\/science.291.5503.484","volume":"291","author":"A Samuelsson","year":"2001","unstructured":"Samuelsson\u00a0A, Towers\u00a0TL, Ravetch\u00a0JV (2001) Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 291:484\u2013486","journal-title":"Science"},{"issue":"1","key":"5303_CR37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1398-9995.2005.00937.x","volume":"61","author":"J Maetzke","year":"2006","unstructured":"Maetzke\u00a0J, Sperfeld\u00a0AD, Scharffetter-Kochanek\u00a0K, Sunderk\u00f6tter\u00a0C (2006) Vesicular and bullous eczema in response to intravenous immunoglobulins (IVIG). Allergy 61(1):145\u2013146","journal-title":"Allergy"},{"key":"5303_CR38","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0025-6196(11)65128-8","volume":"74","author":"D Rayson","year":"1999","unstructured":"Rayson\u00a0D, Lust\u00a0JA, Duncan\u00a0A, Su\u00a0WP (1999) Scleromyxedema: a\u00a0complete response to prednisone. Mayo Clin Proc 74:481\u2013484","journal-title":"Mayo Clin Proc"},{"key":"5303_CR39","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1346-8138.2006.00047.x","volume":"33","author":"YC Lin","year":"2006","unstructured":"Lin\u00a0YC, Wang\u00a0HC, Shen\u00a0JL (2006) Scleromyxedema: an experience using treatment with systemic corticosteroid and review of the published work. J\u00a0Dermatol 33:207\u2013210","journal-title":"J Dermatol"},{"key":"5303_CR40","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1016\/j.jaad.2004.03.023","volume":"51","author":"KB Horn","year":"2004","unstructured":"Horn\u00a0KB, Horn\u00a0MA, Swan\u00a0J, Singhal\u00a0S, Guitart\u00a0J (2004) A\u00a0complete and durable clinical response to high-dose dexamethasone in a\u00a0patient with scleromyxedema. J\u00a0Am Acad Dermatol 51:S120\u2013S123","journal-title":"J Am Acad Dermatol"},{"key":"5303_CR41","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jaad.2004.01.058","volume":"51","author":"JC Sansbury","year":"2004","unstructured":"Sansbury\u00a0JC, Cocuroccia\u00a0B, Jorizzo\u00a0JL, Gubinelli\u00a0E, Gisondi\u00a0P, Girolomoni\u00a0G (2004) Treatment of recalcitrant scleromyxedema with thalidomide in 3\u00a0patients. J\u00a0Am Acad Dermatol 51:126\u2013131","journal-title":"J Am Acad Dermatol"},{"key":"5303_CR42","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1365-4632.2011.05030.x","volume":"52","author":"I Guarenti","year":"2013","unstructured":"Guarenti\u00a0I, Sebastiani\u00a0V, Pinto\u00a0G, de Souza\u00a0PR, de Almeida\u00a0H Jr. (2013) Successful treatment of scleromyxedema with oral thalidomide. Int J Dermatol 52:631\u2013632","journal-title":"Int J Dermatol"},{"key":"5303_CR43","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1468-3083.2007.02420.x","volume":"22","author":"A Martins","year":"2008","unstructured":"Martins\u00a0A, Paiva Lopes\u00a0MJ, Tavares Belo\u00a0R, Rodrigues\u00a0JC (2008) Scleromyxedema\u2014thalidomide therapy. J\u00a0Eur Acad Dermatol Venereol 22:622\u2013624","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5303_CR44","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.semarthrit.2007.10.015","volume":"38","author":"P Efthimiou","year":"2008","unstructured":"Efthimiou\u00a0P, Blanco\u00a0M (2008) Intravenous gammaglobulin and thalidomide may be an effective therapeutic combination in refractory scleromyxedema: case report and discussion of the literature. Semin Arthritis Rheum 38:188\u2013194","journal-title":"Semin Arthritis Rheum"},{"key":"5303_CR45","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jaad.2013.01.028","volume":"69","author":"F Brunet-Possenti","year":"2013","unstructured":"Brunet-Possenti\u00a0F, Hermine\u00a0O, Marinho\u00a0E, Crickx\u00a0B, Descamps\u00a0V (2013) Combination of intravenous immunoglobulins and lenalidomide in the treatment of scleromyxedema. J\u00a0Am Acad Dermatol 69:319\u2013320","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"5303_CR46","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/ajh.25100","volume":"93","author":"J Li","year":"2018","unstructured":"Li\u00a0J, Huang\u00a0XF, Cai\u00a0QQ, Wang\u00a0C, Cai\u00a0H, Zhao\u00a0H, Zhang\u00a0L, Cao\u00a0XX, Gale\u00a0RP, Zhou\u00a0DB (2018) A\u00a0prospective phase\u00a0II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome. Am J Hematol 93(6):803\u2013809","journal-title":"Am J Hematol"},{"issue":"5","key":"5303_CR47","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1600-0609.2012.01772.x","volume":"88","author":"J Ca\u00f1ueto","year":"2012","unstructured":"Ca\u00f1ueto\u00a0J, Labrador\u00a0J, Rom\u00e1n\u00a0C et\u00a0al (2012) The combination of bortezomib and dexamethasone is an efficient therapy for relapsed\/refractory scleromyxedema: a\u00a0rare disease with new clinical insights. Eur J Haematol 88(5):450\u2013454","journal-title":"Eur J Haematol"},{"key":"5303_CR48","first-page":"1071","volume":"137","author":"AM Feasel","year":"2001","unstructured":"Feasel\u00a0AM, Donato\u00a0ML, Duvic\u00a0M (2001) Complete remission of scleromyxedema following autologous stem cell transplantation. Arch Dermatol 137:1071\u20131072","journal-title":"Arch Dermatol"},{"issue":"2","key":"5303_CR49","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.trsl.2014.06.002","volume":"165","author":"N Shayegi","year":"2015","unstructured":"Shayegi\u00a0N, Alakel\u00a0N, Middeke\u00a0JM, Schetelig\u00a0J, Mantovani-L\u00f6ffler\u00a0L, Bornh\u00e4user\u00a0M (2015) Allogeneic stem cell transplantation for the treatment of refractory scleromyxedema. Transl Res 165(2):321\u2013324","journal-title":"Transl Res"},{"issue":"6","key":"5303_CR50","doi-asserted-by":"publisher","first-page":"e213","DOI":"10.1016\/j.clml.2014.06.018","volume":"14","author":"SR Shams","year":"2014","unstructured":"Shams\u00a0SR, Goldstein\u00a0DA, Kaufman\u00a0JL, Mackelfresh\u00a0J, Flowers\u00a0CR, Langston\u00a0AA (2014) Dermato-neuro syndrome in a\u00a0patient treated with autologous stem cell transplant for scleromyxedema. Clin Lymphoma Myeloma Leuk 14(6):e213\u2013e215","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-024-05303-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-024-05303-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-024-05303-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T19:02:39Z","timestamp":1708974159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-024-05303-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["5303"],"URL":"https:\/\/doi.org\/10.1007\/s00105-024-05303-0","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,16]]},"assertion":[{"value":"15 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Sunderk\u00f6tter hat Honorare f\u00fcr Vortr\u00e4ge zu IVIG von der Firma Biotest erhalten (aber nicht zum Thema Skleromyx\u00f6dem). T.\u00a0Bruns und C.\u00a0Pfeiffer geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}